Video Replay: Endpoints at #JPM20 — newsmakers on dealmaking, pricing and manufacturing
On Monday, we held our fourth annual #JPM event — and the team hit a key milestone that I’d like to share with the entire Endpoints News audience: We live-streamed the conversation and had nearly triple the number of executives watching online than we had in the sold-out crowd of 320.
For a media company on a mission to connect the biopharma world in bigger and better ways, we’re proud of how we were able to extend the reach of our franchise event. Paid subscribers were given access to the stream in real time, and now, two days later, we’re opening it up to everyone in this post.
John Carroll, my partner at Endpoints, conducted a marathon 3-hour session that included two panel discussions and a fireside chat with some of the industry’s biggest newsmakers.
The art of the biotech deal was our first panel, and it featured Marianne De Backer (Bayer), Arie Belldegrun (Allogene Therapeutics), Stéphane Bancel (Moderna Therapeutics), Vivek Ramaswamy (Roivant Sciences), and Josh Bilenker (Loxo Oncology by Eli Lilly).
Next, John Chiminski, the CEO of Catalent, and John Carroll had a fascinating one-on-one chat that touched on some of the most critical issues in manufacturing gene therapies and next-gen biologics.
Lastly, we have Talking Points on Pricing, an issue that continues to dominate, and this panel did not disappoint with PhRMA’s Steve Ubl, National MS Society’s Bari Talente, ICER’s Steve Pearson, and bluebird’s Nick Leschly all bringing their sharp perspectives to the Endpoints News audience.
It was a fantastic event and we hope you enjoy the show. We have a full slate of events this year in San Diego, Boston, London, and more and hope to catch you there in person (or online!).
Photography by Jeff Rumans, Endpoints News. Livestream by Spark Digital.